Glomerulonephritis, Membranous

"Glomerulonephritis, Membranous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Descriptor ID	D015433
MeSH Number(s)	C12.777.419.570.363.625 C13.351.968.419.570.363.625 C20.111.535
Concept/Terms	Glomerulonephritis, Membranous Glomerulonephritis, Membranous Glomerulonephritides, Membranous Membranous Glomerulonephritides Membranous Glomerulonephritis Nephropathy, Membranous Membranous Glomerulopathy Glomerulopathy, Membranous Membranous Nephropathy Extramembranous Glomerulopathy Glomerulopathy, Extramembranous Membranous Glomerulonephropathy Glomerulonephropathy, Membranous Idiopathic Membranous Glomerulonephritis Idiopathic Membranous Glomerulonephritis Glomerulonephritides, Idiopathic Membranous Glomerulonephritis, Idiopathic Membranous Idiopathic Membranous Glomerulonephritides Membranous Glomerulonephritides, Idiopathic Membranous Glomerulonephritis, Idiopathic Idiopathic Membranous Nephropathy Membranous Nephropathy, Idiopathic Nephropathy, Idiopathic Membranous Heymann Nephritis Heymann Nephritis Nephritis, Heymann

Below are MeSH descriptors whose meaning is more general than "Glomerulonephritis, Membranous".

Diseases [C]
Male Urogenital Diseases [C12]
Urologic Diseases [C12.777]
Kidney Diseases [C12.777.419]
Nephritis [C12.777.419.570]
Glomerulonephritis [C12.777.419.570.363]
Glomerulonephritis, Membranous [C12.777.419.570.363.625]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urologic Diseases [C13.351.968]
Kidney Diseases [C13.351.968.419]
Nephritis [C13.351.968.419.570]
Glomerulonephritis [C13.351.968.419.570.363]
Glomerulonephritis, Membranous [C13.351.968.419.570.363.625]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Glomerulonephritis, Membranous [C20.111.535]

Below are MeSH descriptors whose meaning is related to "Glomerulonephritis, Membranous".

Below are MeSH descriptors whose meaning is more specific than "Glomerulonephritis, Membranous".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glomerulonephritis, Membranous" by people in this website by year, and whether "Glomerulonephritis, Membranous" was a major or minor topic of these publications.

Bar chart showing 15 publications over 13 distinct years, with a maximum of 2 publications in 2018 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1996	1	0	1
1998	1	0	1
2003	1	0	1
2010	0	1	1
2011	1	0	1
2014	1	0	1
2015	1	0	1
2016	1	0	1
2017	1	0	1
2018	2	0	2
2019	1	0	1
2020	1	1	2

Below are the most recent publications written about "Glomerulonephritis, Membranous" by people in Profiles.

Lin JS, Wang DY, Mamlouk O, Glass WF, Abdelrahim M, Yee C, Abudayyeh A. Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab. J Immunother Cancer. 2020 10; 8(2).

View in: PubMed
Batal I, Vasilescu ER, Dadhania DM, Adel AA, Husain SA, Avasare R, Serban G, Santoriello D, Khairallah P, Patel A, Moritz MJ, Latulippe E, Riopel J, Khallout K, Swanson SJ, Bomback AS, Mohan S, Ratner L, Radhakrishnan J, Cohen DJ, Appel GB, Stokes MB, Markowitz GS, Seshan SV, De Serres SA, Andeen N, Loupy A, Kiryluk K, D'Agati VD. Association of HLA Typing and Alloimmunity With Posttransplantation Membranous Nephropathy: A Multicenter Case Series. Am J Kidney Dis. 2020 09; 76(3):374-383.

View in: PubMed
Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):268-280.

View in: PubMed
Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. Am J Kidney Dis. 2019 02; 73(2):218-229.

View in: PubMed
Malatesta-Muncher R, Eldin KW, Beck LH, Michael M. Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol. 2018 06; 33(6):1089-1092.

View in: PubMed
Pereira M, Muscal E, Eldin K, Hicks MJ, Sagcal-Gironella ACP, DeGuzman M, Wenderfer SE. Clinical presentation and outcomes of childhood-onset membranous lupus nephritis. Pediatr Nephrol. 2017 Dec; 32(12):2283-2291.

View in: PubMed
Boneparth A, Wenderfer SE, Moorthy LN, Radhakrishna SM, Sagcal-Gironella AC, von Scheven E. Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Lupus. 2017 Mar; 26(3):299-306.

View in: PubMed
Truong LD, Seshan SV. Enigma (partially) resolved: phospholipase A2 receptor is the cause of "idiopathic" membranous glomerulonephritis. Am J Physiol Renal Physiol. 2015 Dec 15; 309(12):F1000-2.

View in: PubMed
Li Y, Yan M, Yang J, Raman I, Du Y, Min S, Fang X, Mohan C, Li QZ. Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation. Stem Cell Res Ther. 2014 Jan 30; 5(1):19.

View in: PubMed
Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, Wilson C, Srivastava SK, Dietrich A, Walz K, Kerjaschki D, Ruiz P, Dryer S, Sever S, Dinda AK, Faul C, Reiser J. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem. 2013 Dec 20; 288(51):36598-609.

View in: PubMed

People

Explore

Similar Concepts

Top Journals